Shares of Spectral Diagnostics Inc. (OTCMKTS:EDTXF - Get Free Report) traded down 5.2% during mid-day trading on Friday . The company traded as low as $0.61 and last traded at $0.61. 9,014 shares traded hands during trading, a decline of 9% from the average session volume of 9,897 shares. The stock had previously closed at $0.64.
Spectral Diagnostics Stock Down 5.2%
The business has a 50-day moving average price of $0.60 and a 200-day moving average price of $0.49. The firm has a market capitalization of $174.31 million, a price-to-earnings ratio of -8.72 and a beta of 0.23.
Spectral Diagnostics (OTCMKTS:EDTXF - Get Free Report) last announced its earnings results on Friday, May 9th. The company reported ($0.03) earnings per share for the quarter. The company had revenue of $0.40 million during the quarter.
About Spectral Diagnostics
(
Get Free Report)
Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Spectral Diagnostics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spectral Diagnostics wasn't on the list.
While Spectral Diagnostics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
